These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17069719)

  • 1. [Hepatitis C in HIV infected patients].
    Bukh J; Nielsen JO
    Ugeskr Laeger; 2006 Oct; 168(42):3599. PubMed ID: 17069719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Halota W; Pawłowska M
    Przegl Epidemiol; 2002; 56 Suppl 5():41-5. PubMed ID: 15553071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV and HCV infections--clinical implications].
    Pawłowska M; Halota W; Grabczewska E
    Przegl Epidemiol; 2004; 58 Suppl 1():71-5. PubMed ID: 15807161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HBV and HCV co-infections in HIV positive patients in the "HAART era": new challenges].
    Laufer NL; Quarleri JF; Bouzas MB; Perez HM; Salomon H; Cahn PE
    Medicina (B Aires); 2007; 67(1):82-91. PubMed ID: 17408028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
    Bellini C; Keiser O; Chave JP; Evison J; Fehr J; Kaiser L; Weber R; Vernazza P; Bernasconi E; Telenti A; Cavassini M;
    HIV Med; 2009 Jan; 10(1):12-8. PubMed ID: 18795964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis.
    Chilton D; Edwards SG; Pellegrino P; Miller RF
    Thorax; 2008 Oct; 63(10):935-6. PubMed ID: 18820121
    [No Abstract]   [Full Text] [Related]  

  • 9. [Almost 6,000 double-infected patients in Germany. Hepatitis C burden in HIV patients].
    MMW Fortschr Med; 2000; 142(3 Suppl):19. PubMed ID: 10893954
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C virus genotypes distribution and viral load level among HIV-coinfected patients].
    Bolcic F; Laufer N; Quarleri J
    Acta Gastroenterol Latinoam; 2008 Dec; 38(4):307. PubMed ID: 19160588
    [No Abstract]   [Full Text] [Related]  

  • 12. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
    Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
    J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current opportunities for treatment of chronic hepatitis C in patients with HIV co-infection].
    Inglot M; Szymczak A; Gasiorowski J
    Przegl Epidemiol; 2008; 62(2):383-91. PubMed ID: 18807485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
    Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
    AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis.
    Martín-Carbonero L; Barreiro P; Jiménez-Galán G; García-Berriguete R; Núñez M; Ríos P; González-Lahoz J; Soriano V
    J Viral Hepat; 2007 Jun; 14(6):392-5. PubMed ID: 17501759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
    Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
    Werneck-Silva AL; Prado IB
    J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver ultrastructural morphology and mitochondrial DNA levels in HIV/hepatitis C virus coinfection: no evidence of mitochondrial damage with highly active antiretroviral therapy.
    Matsukura M; Chu FF; Au M; Lu H; Chen J; Rietkerk S; Barrios R; Farley JD; Montaner JS; Montessori VC; Walker DC; Côté HC
    AIDS; 2008 Jun; 22(10):1226-9. PubMed ID: 18525271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection.
    Cooper CL; Mills E; Angel JB
    AIDS; 2007 Jan; 21(1):71-6. PubMed ID: 17148970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.